BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2009
View Archived Issues
NK3 receptor antagonists claimed by Roche
Read More
GlaxoSmithKline presents novel IGF-1R inhibitors for cancer treatment
Read More
Novel nAChR receptor modulators claimed by NeuroSearch
Read More
Schering-Plough presents novel gamma-secretase modulators
Read More
Novel LXRbeta ligands discovered by Roche
Read More
GSK-962040: A novel small-molecule motilin receptor agonist for gastric stasis
Read More
Paladin files new drug submission for Trelstar 6-month formulation
Read More
FDA approves Dara's IND to begin phase I studies in humans of DB-959 for type 2 diabetes
Read More
IMUC and Formatech sign agreement for development of optimal formulation of ICT-121
Read More
Advaxis submits ADXS-11-001 to FDA for orphan drug designation
Read More
Celator enrolls first patient in phase II CPX-351 trial in acute myeloid leukemia
Read More
Preclinical data on anti-HCV drug PF-00868554 published
Read More
Custirsen combined with docetaxel shows increased efficacy and safety in prostate cancer
Read More
Fosrenol launched in Japan for hyperphosphatemia
Read More
NVC-422 shows antifungal activity in animal model of dermatophytosis
Read More
WAY-207024 is a novel orally active antagonist of GnRH receptor
Read More
Icagen initiates senicapoc study in patients with exercise-induced asthma
Read More
Medicure cleared to commence phase II Avastrem trial for tardive dyskinesia
Read More
Merrion commences dosing of Orazol in U.S. clinical study
Read More
StemEx receives orphan medicinal product designation in Europe
Read More
TrialNet centers begin Diamyd vaccine studies for recent-onset type 1 diabetes
Read More
Targacept to discontinue development of TC-6499 for neuropathic pain
Read More
Nanotherapeutics presents update on clinical development programs
Read More
Dynavax and AstraZeneca extend research collaboration in asthma and COPD
Read More
Taiho and Toray initiate codevelopment of beta3-adrenoceptor agonist TRK-380/TAC-301
Read More